For press inquiries click here to contact us.
Nurix Therapeutics
Partnered with Gilead and Sanofi, protein degradation specialist Nurix bags $120M to chart its own clinical path
ALX Oncology
Corey Goodman marshals $105M mega-round for his CD47 upstart, looking to break new ground in PhII
GenapSys
GenapSys raises $75M to bring its tabletop DNA sequencer to Asia amid coronavirus outbreak
Relay Therapeutics
Scientists at the Movies: Relay Therapeutics CEO Sanjiv Patel on The Long Run
Element Biosciences
Ex-Illumina director’s rival startup Element raises $80M, hiring 100 people
Kinnate Biopharma
Kinnate jumps onto the biotech stage with $74.5M and a fledgling cancer drug pipeline
Venatorx Pharmaceuticals, Inc.
Malvern drugmaker is hopeful where others struggle: Fighting deadly ‘superbugs’
GenapSys
Biotech With iPad-Sized Gene Sequencer Gets Foresite-Led Funding
Turning Point Therapeutics
How Turning Point Therapeutics became a 2019 IPO standout
Please see important disclaimers in the Terms section.
